Here's something you might be interested in.
Ask a Hipster — Advice you didn't know you needed
Big Screen — Movie commentary
Blurt — Music's inside track
Booze News — San Diego spirits
Classical Music — Immortal beauty
Classifieds — Free and easy
Cover Stories — Front-page features
Drinks All Around — Bartenders' drink recipes
Excerpts — Literary and spiritual excerpts
Feast! — Food & drink reviews
Feature Stories — Local news & stories
Fishing Report — What’s getting hooked from ship and shore
From the Archives — Spotlight on the past
Golden Dreams — Talk of the town
The Gonzo Report — Making the musical scene, or at least reporting from it
Letters — Our inbox
Movies@Home — Local movie buffs share favorites
Movie Reviews — Our critics' picks and pans
Musician Interviews — Up close with local artists
Neighborhood News from Stringers — Hyperlocal news
News Ticker — News & politics
Obermeyer — San Diego politics illustrated
Outdoors — Weekly changes in flora and fauna
Overheard in San Diego — Eavesdropping illustrated
Poetry — The old and the new
Reader Travel — Travel section built by travelers
Reading — The hunt for intellectuals
Roam-O-Rama — SoCal's best hiking/biking trails
San Diego Beer — Inside San Diego suds
SD on the QT — Almost factual news
Sheep and Goats — Places of worship
Special Issues — The best of
Street Style — San Diego streets have style
Surf Diego — Real stories from those braving the waves
Theater — On stage in San Diego this week
Tin Fork — Silver spoon alternative
Under the Radar — Matt Potter's undercover work
Unforgettable — Long-ago San Diego
Unreal Estate — San Diego's priciest pads
Your Week — Daily event picks
Chad and Akis get popped
Two brokers guilty of insider trading in biotech stock
Two local stockbrokers, Chad Wiegand and Akis Eracleous, pleaded guilty in federal court today (June 9) to insider trading in the stock of San Diego–based biotech Ardea Biosciences, now a wholly owned subsidiary of London-based pharmaceutical AstraZeneca.
The brokers worked for National Planning Corporation, a brokerage that is part of National Planning Holdings, which in turn is affiliated with Jackson National Life Insurance Company.
As detailed by the U.S. attorney's office, Wiegand got inside information on Ardea from his brother-in-law, who oversaw Ardea's computer operations. The brother-in-law is identified as a co-conspirator, but not by name. Wiegand got inside information that AstraZeneca was going to buy Ardea; he traded on that inside information for himself and his customers. Ardea stock zoomed 51.7 percent the day of the announcement.
Wiegand provided the inside information to Eracleous, who traded on it and shared the secrets with others who paid some of their profits back to Eracleous. All told, profits on the illegal insider trading were "hundreds of thousands of dollars," according to the U.S. attorney's office.
In their plea agreement, Wiegand and Eracleous admitted trading on inside information on Ardea on other occasions between 2009 and 2012.
Here's something you might be interested in.
Chad and Akis get popped
Two brokers guilty of insider trading in biotech stock
Chad and Akis get popped
Two brokers guilty of insider trading in biotech stock
Two local stockbrokers, Chad Wiegand and Akis Eracleous, pleaded guilty in federal court today (June 9) to insider trading in the stock of San Diego–based biotech Ardea Biosciences, now a wholly owned subsidiary of London-based pharmaceutical AstraZeneca.
The brokers worked for National Planning Corporation, a brokerage that is part of National Planning Holdings, which in turn is affiliated with Jackson National Life Insurance Company.
As detailed by the U.S. attorney's office, Wiegand got inside information on Ardea from his brother-in-law, who oversaw Ardea's computer operations. The brother-in-law is identified as a co-conspirator, but not by name. Wiegand got inside information that AstraZeneca was going to buy Ardea; he traded on that inside information for himself and his customers. Ardea stock zoomed 51.7 percent the day of the announcement.
Wiegand provided the inside information to Eracleous, who traded on it and shared the secrets with others who paid some of their profits back to Eracleous. All told, profits on the illegal insider trading were "hundreds of thousands of dollars," according to the U.S. attorney's office.
In their plea agreement, Wiegand and Eracleous admitted trading on inside information on Ardea on other occasions between 2009 and 2012.
Comments